Cranial repair patients
Conditions
Interventions
GA+SNB :General anesthesia combined with scalp nerve block group
( GA+SNB+EA ):General anesthesia combined with scalp nerve block and electroacupuncture treatment group
Sponsors
The First Affiliated Hospital of Shihezi University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1)Age range: 18-75 years old. 2) Body mass index: 18kg/m 2 = BMI = 28kg/m 2; 3) American Society of Anesthesiologists (ASA) class I-II. (iii) American Society of Anesthesiologists (ASA) class I-II; (iv) All patients had severe craniocerebral trauma cerebral hemorrhage or cerebral hemorrhage. All patients had severe craniocerebral trauma and cerebral hemorrhage after decompression of the large bone flap; 5) No intracranial injury after DC. 5)No history of intracranial infection after DC no history of incision infection no obvious brain bulge in the defect localization in the standing position no intracranial hypertension and no lung infection. Those without intracranial hypertension control of pulmonary infection no coagulation disorders and no other serious diseases. (vi) Elective cranial bone repair surgery; and (vii) Agree to undergo cranial bone repair surgery and sign the surgical consent form.
Exclusion criteria
Exclusion criteria: 1) Presence of serious systemic diseases including systemic malnutrition immune system diseases liver and kidney functions severe abnormalities uncontrollable hyperglycemia malignant tumors etc; 2) exclude patients with infections such as pneumonia; 3) severe cardiac pulmonary renal and immune system diseases 3)Serious heart lung kidney immune system diseases; 4)History of opioid addiction. 4) History of opioid addiction; 5) Ropivacaine allergy. 5)History of allergy to ropivacaine; 5)History of allergy to ropivacaine. (vii) Abnormalities of the neuropsychiatric system; (viii) Disapproval of participation in the experiment. 8) Do not agree to participate in this experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| C Reactive proteins; | — |
Secondary
| Measure | Time frame |
|---|---|
| postoperative complication;leucocyte;Total analgesic use;Antiemetic drugs Usage; | — |
Countries
china
Contacts
Public Contactyujiao zhao
The First Affiliated Hospital of Shihezi University
Outcome results
None listed